28
Participants
Start Date
December 9, 2019
Primary Completion Date
December 20, 2019
Study Completion Date
December 23, 2019
Epinephrine (0.125 mg/inhalation)
Participants will self-administer 2 inhalations of Epinephrine (0.125 mg/inhalation) for a total dosage of 0.25 mg.
Epinephrine Injection Auto-Injector (0.3mg/0.3mL)
Participants will receive an intramuscular injection of Epinephrine via Auto-Injector (0.30 mg of epinephrine solution in 0.30 mL). The 0.30 mL dose will be given perpendicularly as a single deep intramuscular injection into the anterolateral aspect of the thigh.
Albuterol Sulfate (0.09 mg/inhalation)
Participants will self-administer 2 inhalations of Albuterol Sulfate (0.09 mg/inhalation) for a total dosage of 0.18 mg.
Amphastar Study Site 0035, Cypress
Lead Sponsor
Amphastar Pharmaceuticals, Inc.
INDUSTRY